Tech Company M&A Transactions
Proprius Pharmaceuticals Acquisition
Proprius Pharmaceuticals, operating out of San Diego, was acquired by Cypress Bioscience. Cypress Bioscience disclosed that the acquisition price was $75 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/25/2008
Transaction Type
M&A
Amount
$75,000,000
M&A Terms
Cypress will acquire Proprius in a transaction that includes an upfront payment of $37.5 million in cash as well as an additional $37.5 million in potential milestone-related payments associated with the development of Proprius' therapeutic candidates.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12264 El Camino Real 300
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Not Recorded
Overview
Proprius Pharmaceuticals is a specialty pharma company which develops personalized medicine solutions in rheumatology and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Walsh
Chief Scientific Officer
DAvid Anderson
VP - Bus. Development
Douglas Richards
VP - Marketing
Patricia Swartwood
VP - R & D
Thierry Dervieux
VP - Regulatory Affairs
Marilyn Carlson
Browse more venture capital transactions:
Prev: 2/25/2008: Adconion venture capital transaction
Next: 2/25/2008: Trupanion venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs